in this issue
Markets :: Basic Chemicals :: Petrochemicals :: Caprolactam
DSM's fourth-quarter net profit down 75% despite higher sales
7:37 AM MST | February 20, 2013 | Francinia Protti-Alvarez
DSM's fourth-quarter 2012 net profit fell by 75%, to €21 million ($28 million), compared with the €85 million reported in the fourth quarter a year earlier, the company said today. Ebitda was also down 17%, to €243 million. Net sales went up marginally from €2.23 billion during the last quarter of 2011, to €2.27 billion during the same period last year—about a 2% increase. In DSM's life sciences division, the nutrition business contributed just over 40% of total sales, reporting €923 million, compared with €865...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee